Back to search

Peptide record

TPDB42890

#5(D93-F112) Anticancer standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42890
#5(D93-F112)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 30-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGDQEIKFKVETLECREMWKGF
Physicochemical Analysis
C165H276N62O43S2
ANHPSY
R
3880.52
11.89
12
5
7
+7
14.94
-1.783
35.67
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
5500
141.73
3
Residue Composition
number
0
A
9
R
0
N
1
D
1
C
4
E
1
Q
3
G
0
H
1
I
1
L
3
K
1
M
2
F
0
P
0
S
1
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 9 N: 0 D: 1 C: 1 E: 4 Q: 1 G: 3 H: 0 I: 1 L: 1 K: 3 M: 1 F: 2 P: 0 S: 0 T: 1 W: 1 Y: 0 V: 1
Chemical Descriptors
30
C165H276N62O43S2
3880.52
11.89
+7
14.94
-1.783
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-B
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.